AETHLON MEDICAL INC·4

Apr 1, 7:27 PM ET

BROENNIMAN EDWARD G 4

Research Summary

AI-generated summary

Updated

Aethlon Medical Director Edward Broenniman Forfeits 89 Shares

What Happened
Edward G. Broenniman, a director of Aethlon Medical (AEMD), had 357 vested restricted stock units (RSUs) converted to common shares on 2026-03-31 and forfeited 89 of those shares to satisfy tax withholding obligations. The withheld shares were valued at $2.19 each, totaling approximately $195. This was a tax-withholding forfeiture (transaction code F), not an open-market sale or purchase.

Key Details

  • Transaction date: 2026-03-31; reporting (filed) date: 2026-04-01. No late filing flag indicated.
  • Withheld/forfeited: 89 shares at $2.19 per share; total value ≈ $195.
  • Underlying award: conversion of 357 vested RSUs (per footnote referencing a grant reported on Form 4 filed 2025-04-25).
  • Shares owned after the transaction: not specified in the provided filing.
  • Transaction code F = tax withholding (shares withheld to cover tax liability).

Context
This was a routine tax-withholding action tied to RSU vesting (a common administrative event), not a directional buy or sell intended to signal sentiment. For retail investors, forfeitures for tax withholding generally do not indicate insider confidence or concern about the company’s prospects.